The world
of the infinitely small

RECENT PUBLICATIONS

WORKSHOP

Priscille BRODIN from the team "Chemical Genomics of Intracellular Mycobacteria" at CIIL is co-organizing a workshop on "Host and pathogen heterogeneity in tuberculosis" at Hyderabad on February 2025.

Check out for more details : HERE

INTERNSHIPS

For all internship applications, please send your request directly to the group leader of the research area that you are interested in :

1- Chemical Genomics of Intracellular Mycobacteria : Priscille Brodin
2- Microbiology's Platypus (MP): Damien Devos
3- Molecular and cellular virology: Jean Dubuisson
4- Apicomplexa Parasite Integrative Biology : Mathieu Gissot
5- Opportunist Infection, Immunity, Environment & Lung Diseases :  Philippe Gosset
6- Mechanobiology of Host-Microbe Interactions(MoHMI) : Alexandre Grassart
7- Chemical Biology of Antibiotics :  Ruben Hartkoorn
8- Biology of Apicomplexan Parasites : Jamal Khalife
9- Cellular Microbiology And Physics Of Infection : Frank Lafont
10- Pulmonary Immunity : Phillippe LASSALLE

11- Chemical Biology of Flatworms : Oleg Melnyk
12- Research on Mycobacteria and Bordetella : Nathalie Mielcarek
13- Tropical Biome & Immuno-Pathophysiology : Sylviane Pied
14- Chronicity of Viral Infections (CVI) : Fernando Real
15- Plague & Yersinia pestis :  Florent Sebbane
16- Bacteria, Antibiotics and Immunity : Jean Claude Sirard
17- Influenza, Immunity and Metabolism : François Trottein
18- Ecology & Physiopathology of Intestinal Protozoa : Eric Viscogliosi

 

 

 

 

 

1- Apicomplexa Parasite Integrative Biology :              Contact
2- Bacteria, Antibiotics & Immunity :                             Contact
3- Biology of Apicomplex Parasites :                            Contact
4- Cellular Microbiology & Physics of Infection :           Contact
5- Chemical Biology of Antibiotics :                              Contact
6- Chemical Biology of Flatworms :                              Contact
7- Chemogenomics of Intracellular Mycobacteria :      Contact
8- Ecology & Physiopathology of Intestinal Protozoa : Contact
9- Influenza, Immunity & Metabolism :                         Contact
10- Lung Immunity :                                                     Contact
11- Molecular & Cellular Virology :                               Contact
12- Opportunistic Infections, Immunity, Environment & Lung Diseases: Contact
13- Plague & Yersinia pestis :                                      Contact
14- Research on Mycobacteria and Bordetella:           Contact
15- Tropical Biomes & Immuno-Pathophysiology :      Contact
16- Mechanobiology of Host-Microbe Interactions :     Contact

NEWS


Titre du document 80 seconds to learn about the Centre's scientific themes

Our video chanel


Where are we with antiviral treatments against Covid-19?

Third episode in the series dedicated to researching Covid-19. This webinar is moderated by Marie Treibert, science popularizer on the La Boîte à curiosités channel. She questions Sandrine Belouzard, virologist and CNRS researcher, who answers all questions relating to antivirals in the treatment of Covid-19. What is the difference between a vaccine and an antiviral treatment? How does an antiviral work? Who will benefit from it? Do we favor therapeutic repositioning or research for a new drug? Through definitions, a press review and an interview, this webinar takes stock of the subject.


One year after the first cases of COVID-19, researchers of the Center for Infection & Immunity of Lille present the current knowledge on SARS-CoV-2 in the context of a series of conferences organized by the Lille Research Taskforce on COVID-19, in partnership with the Society of Sciences, Agriculture and Arts of Lille.


What's CORONAVIRUS ?

Researchs against Covid-19 at the Institut Pasteur in Lille.

Coronaviruses, specificities and prospects for treatment by Jean Dubuisson, director of the Center for Infection & Immunity of Lille


"While bats are not to blame for everything, they have played a role in the transmission of at least 11 viruses" ...

COVID-19: Jean Dubuisson tells us about ANTI-CoV, a project supported by the FRM